Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer

Clinical trial NCT01171755 · TERMINATED

Trial details

NCT number: NCT01171755
Sponsor: Samsung Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2008-02-01
Primary completion: 2009-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.